Sai Life Sciences, one of India’s fastest growing contract research, development and manufacturing organizations (CRO-CDMO), has opened a new high-potency API (HPAPI) manufacturing facility at its cGMP API manufacturing campus in Bidar, India. The addition of this new facility expands the company’s expertise across HPAPI development and manufacturing, providing its customers with a streamlined pathway […]

The post Sai Life Sciences Opens High-Potency API Manufacturing Facility first appeared on World Pharma Today.